News

NBC Bay Area: Superhero Runners Brave Weather for Union City Fun Run Benefiting Parkinson's

Morning fun run in the East Bay saw hundreds of super heroes brave the rain and cold to help raise money for those affected by Parkinson's. All proceeds from the run will go to the Parkinson's Foundation Moving Day event.

News

Westword.com: Parkinson’s Foundation to Host First Marijuana Conference in Denver

On March 6 and 7, the Parkinson's Foundation will host its first-ever conference on medical marijuana in Denver. The conference will address potential risks and benefits of treating Parkinson's disease with medical cannabis by bringing together a diverse group of experts from academia, clinics, industry, government and the Parkinson's community to establish a consensus on medical marijuana use in Parkinson’s disease.

News

Brain & Life: Genes Aren't Destiny

Sales of direct-to-consumer genetic tests are booming, but users should understand the possible implications of taking one and consult a medical professional about the results. James Beck, PhD, Parkinson's Foundation Chief Scientific Officer, is quoted.

News

U.S. News: Possible Parkinson's 'Pandemic' Looms: Report

The number of people living with Parkinson's worldwide could double in the next two decades, experts project. Study authors include multiple neurologists from Centers of Excellence: Michael S. Okun, MD, Ray Dorsey, MD, and Bastiaan R. Bloem, MD.

News

Miami Herald: Without A Glass Ceiling in Her Way, The Only Place for Terranova’s New President, Mindy Mcllroy, To Go Is Up

After Mindy McIlroy received her Parkinson’s diagnosis four years ago, she was afraid to tell her employer. Terranova, and her industry peers, responded with overwhelming support. Parkinson’s Foundation mentioned, as Mindy serves on our Board.

News

Parkinson’s News Today: In U.S., Parkinson’s Diagnosis Linked to Higher Healthcare Use, Spending, Study Shows

A PD diagnosis is associated with greater Medicare costs and out-of-pocket spending, according to a population-based Parkinson’s Foundation study. The Parkinson’s Foundation study is explained and John L. Lehr, CEO, and James Beck, PhD, the Foundation’s chief scientific officer, is quoted.

News

Breaking News: Boston Scientific: Boston Scientific Launches Vercise™ Primary Cell And Vercise Gevia™ Deep Brain Stimulation Systems With Directional Leads

Parkinson's Foundation cited in Boston Scientific Press Release: MARLBOROUGH, Mass., Jan. 24, 2019 -- Boston Scientific Corporation (NYSE: BSX) has launched the Vercise™Primary Cell (PC) and Vercise Gevia™ Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia™ Directional Lead. The new systems, which were recently approved by the U.S. Food and Drug Administration (FDA), feature technology designed to allow physicians to control the range, shape, position and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy. The Vercise Cartesia Directional Lead was the first directional lead introduced to the global market when it launched in Europe in 2015.

News

U.S. News: Good News, Bad News on Levodopa for Parkinson's Disease

The most potent drug available for Parkinson's, levodopa, treats symptoms of the disease, but does not ease or increase its still-mysterious underlying causes, a new clinical trial has concluded. Dr. Michael S. Okun, Parkinson’s Foundation national medical director, is quoted.

News

MD Magazine: The Perfect Storm: When Parkinson Patients Enter the Hospital

People with Parkinson’s generally experience a longer hospital stay than those entering the hospital for the same diagnosis without PD, and can develop more complications. This article cites Parkinson’s Outcomes Project data and promotes the Foundation’s Aware in Care kit as an “excellent resource for patients with PD who are going to the hospital.”

News

Inside Philanthropy: How Are Funders Stepping Up in the Fight Against Still-Untreatable Neurodegenerative Diseases?

Organizations and non-profits funded millions of dollars in neurogenerative disease research in 2018. The Parkinson’s Foundation is highlighted for its $6.2 million research grant investment.